HFrEF Patient With Hyperkalaemia
Published: 09 December 2022
Watch this insightful case study presented by Dr Shelley Zieroth where she presents an HF patient who has moderate to severe hyperkalaemia.
These case studies, and their management strategies, will be discussed in a live roundtable discussion coming soon - register now to receive updates on the roundtable.
Watch these case studies today, answer the quick polls, and register to attend the broadcast to hear from the panel, who will also be offering practical solutions to challenges experienced in daily practice.
This programme is supported by an unrestricted educational grant from AstraZeneca.
More from this programme
Director of the Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St. Boniface Hospital in Winnipeg, CA.
She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba. She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Immediate Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She serves as Co-Chair of Canada’s largest annual heart failure meeting, HF Update and serves as Scientific Planning Committee Chair for the Canadian Cardiovascular Congress hosted by the Canadian Cardiovascular Society. She is currently President-elect of the Federation of Medical Women of Canada.